SignatureFD’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $907K | Sell |
1,614
-30
| -2% | -$19.2K | 0.01% | 429 |
|
|
2025
Q4 | $1.11M | Buy |
1,644
+187
| +13% | +$127K | 0.02% | 353 |
|
|
2025
Q3 | $931K | Buy |
1,457
+93
| +7% | +$56.4K | 0.01% | 400 |
|
|
2025
Q2 | $731K | Sell |
1,364
-52
| -4% | -$24.9K | 0.01% | 444 |
|
|
2025
Q1 | $595K | Buy |
1,416
+154
| +12% | +$66.9K | 0.01% | 468 |
|
|
2024
Q4 | $522K | Sell |
1,262
-108
| -8% | -$47.4K | 0.01% | 511 |
|
|
2024
Q3 | $692K | Sell |
1,370
-62
| -4% | -$30.1K | 0.01% | 427 |
|
|
2024
Q2 | $698K | Buy |
1,432
+173
| +14% | +$86.8K | 0.01% | 400 |
|
|
2024
Q1 | $680K | Buy |
1,259
+11
| +0.9% | +$6.01K | 0.01% | 421 |
|
|
2023
Q4 | $693K | Buy |
1,248
+50
| +4% | +$23.5K | 0.02% | 372 |
|
|
2023
Q3 | $524K | Buy |
1,198
+60
| +5% | +$29.9K | 0.01% | 431 |
|
|
2023
Q2 | $572K | Sell |
1,138
-52
| -4% | -$24.9K | 0.01% | 398 |
|
|
2023
Q1 | $595K | Buy |
1,190
+46
| +4% | +$22K | 0.02% | 380 |
|
|
2022
Q4 | $467K | Buy |
1,144
+278
| +32% | +$108K | 0.01% | 432 |
|
|
2022
Q3 | $282K | Sell |
866
-84
| -9% | -$30.9K | 0.01% | 554 |
|
|
2022
Q2 | $333K | Buy |
950
+329
| +53% | +$134K | 0.01% | 500 |
|
|
2022
Q1 | $340K | Buy |
621
+66
| +12% | +$34.7K | 0.01% | 536 |
|
|
2021
Q4 | $365K | Buy |
555
+37
| +7% | +$23.2K | 0.01% | 497 |
|
|
2021
Q3 | $322K | Buy |
518
+83
| +19% | +$55.8K | 0.01% | 511 |
|
|
2021
Q2 | $275K | Buy |
435
+95
| +28% | +$52.5K | 0.01% | 542 |
|
|
2021
Q1 | $166K | Buy |
340
+64
| +23% | +$32.1K | 0.01% | 674 |
|
|
2020
Q4 | $138K | Buy |
276
+49
| +22% | +$21.9K | 0.01% | 658 |
|
|
2020
Q3 | $89K | Sell |
227
-32
| -12% | -$11.8K | ﹤0.01% | 743 |
|
|
2020
Q2 | $86K | Buy |
259
+14
| +6% | +$4.05K | 0.01% | 741 |
|
|
2020
Q1 | $59K | Buy |
245
+23
| +10% | +$6K | 0.01% | 832 |
|
|
2019
Q4 | $58K | Sell |
222
-201
| -48% | -$53K | ﹤0.01% | 914 |
|
|
2019
Q3 | $115K | Buy |
423
+24
| +6% | +$6.68K | 0.01% | 596 |
|
|
2019
Q2 | $110K | Buy |
399
+49
| +14% | +$12.1K | 0.01% | 585 |
|
|
2019
Q1 | $78K | Sell |
350
-269
| -43% | -$55.5K | 0.01% | 719 |
|
|
2018
Q4 | $115K | Buy |
619
+46
| +8% | +$9.43K | 0.01% | 540 |
|
|
2018
Q3 | $143K | Sell |
573
-403
| -41% | -$97.8K | 0.01% | 517 |
|
|
2018
Q2 | $213K | Buy |
976
+428
| +78% | +$88.2K | 0.02% | 390 |
|
|
2018
Q1 | $105K | Buy |
+548
| New | +$101K | 0.01% | 516 |
|
|
2016
Q4 | – | Sell |
-300
| Closed | -$34K | – | 678 |
|
|
2016
Q3 | $34K | Hold |
300
| – | – | 0.01% | 643 |
|
|
2016
Q2 | $28K | Hold |
300
| – | – | ﹤0.01% | 625 |
|
|
2016
Q1 | $23K | Hold |
300
| – | – | ﹤0.01% | 624 |
|
|
2015
Q4 | $22K | Hold |
300
| – | – | ﹤0.01% | 541 |
|
|
2015
Q3 | $22K | Hold |
300
| – | – | 0.01% | 505 |
|
|
2015
Q2 | $19K | Hold |
300
| – | – | ﹤0.01% | 482 |
|
|
2015
Q1 | $23K | Sell |
300
-90
| -23% | -$7K | 0.01% | 409 |
|
|
2014
Q4 | $29K | Buy |
390
+300
| +333% | +$21K | 0.01% | 361 |
|
|
2014
Q3 | $5K | Buy |
90
+40
| +80% | +$2.53K | ﹤0.01% | 538 |
|
|
2014
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 659 |
|
|
2014
Q1 | $3K | Sell |
50
-70
| -58% | -$4.17K | ﹤0.01% | 579 |
|
|
2013
Q4 | $6K | Buy |
+120
| New | +$6.32K | ﹤0.01% | 498 |
|
Other funds holding IDXX
VCM
VPM
SignatureFD's IDXX Position: Q1 2026 in Review
SignatureFD reduced its Idexx Laboratories (IDXX) stake by 1.8% in Q1 2026, selling an estimated $19.2K and leaving 1,614 shares worth $907K. The position accounts for 0.01% of the portfolio, ranked #429.
SignatureFD first reported a position in IDXX in Q4 2013 and has held it in 45 quarters since. The position peaked at $1.11M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- SignatureFD held 1,614 shares of Idexx Laboratories worth $907K as of Q1 2026.
- SignatureFD sold 30 Idexx Laboratories shares in Q1 2026, an estimated $19.2K.
- Idexx Laboratories made up 0.01% of SignatureFD's portfolio in Q1 2026, its #429 holding.
- SignatureFD first reported a position in Idexx Laboratories in Q4 2013 and has held it in 45 quarters since.
- SignatureFD's Idexx Laboratories position peaked at $1.11M in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.